** Shares of Biome Australia Ltd BIO.AX jump as much as
17.7% to A$0.080, posting their biggest intraday pct gain since
Dec 8
** The biotech services firm says it has surpassed its FY23
sales revenue target with half a month of trading remaining
** Says looking forward to strong growth in FY24
** Adds, co continues to commercialise novel clinical
research, which will lead to a number of key product launches in
H1 FY24
** Shares hit their highest level since May 12
** BIO stock down 4.2% this year, as of last close
($1 = 1.4721 Australian dollars)
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))